Medicare Enrolled

Dr. Jaisri Maharaj, M.D.

Endocrinology · Los Gatos, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
15899 LOS GATOS ALMADEN RD STE 12, Los Gatos, CA 95032
4083582663
In practice since 2010 (15 years)
NPI: 1629380464 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Maharaj from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maharaj? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Maharaj

Dr. Jaisri Maharaj is an endocrinology specialist in Los Gatos, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Maharaj performed 588 Medicare services across 283 unique beneficiaries.

Between the years covered by Open Payments, Dr. Maharaj received a total of $3,630 from 38 pharmaceutical and/or device companies across 195 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Maharaj is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ 588 Medicare services $3,630 industry payments

Medicare Practice Summary

Medicare Utilization ↗
588
Medicare services
Bottom 46% in CA for endocrinology
283
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~39 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
314 $113 $460
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
103 $117 $460
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
64 $31 $143
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
38 $156 $585
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
26 $8 $9
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
23 $148 $635
New patient office visit, complex (60-74 min) 20 $176 $770
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,630
Total received (2018-2024)
Avg $605/year across 6 years
Top 34% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
195
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,630 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,236
2023
$423
2022
$644
2021
$1,203
2020
$24
2018
$100

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$260
Antares Pharma, Inc.
$196
BETA BIONICS, INC.
$159
Dexcom, Inc.
$91
Lilly USA, LLC
$89
Amgen Inc.
$82
Bayer Healthcare Pharmaceuticals Inc.
$80
Radius Health, Inc.
$50
Abbott Laboratories
$42
ABBVIE INC.
$34
Hologic Sales and Service, LLC
$30
Alexion Pharmaceuticals, Inc.
$24
Xeris Pharmaceuticals, Inc.
$23
VIVUS LLC
$22
SANOFI-AVENTIS U.S. LLC
$20
Verity Pharmaceuticals Inc.
$20
Almatica Pharma LLC
$15
Top 3 companies account for 49.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$606
Abbott Laboratories
$439
Lilly USA, LLC
$356
Antares Pharma, Inc.
$196
Supernus Pharmaceuticals, Inc.
$168
BETA BIONICS, INC.
$159
Amgen Inc.
$151
Xeris Pharmaceuticals, Inc.
$143
Zealand Pharma US, Inc.
$117
Dexcom, Inc.
$115
Radius Health, Inc.
$106
EMD Serono, Inc.
$100
AbbVie Inc.
$95
SANOFI-AVENTIS U.S. LLC
$81
Bayer Healthcare Pharmaceuticals Inc.
$80
Medtronic, Inc.
$71
Corcept Therapeutics
$65
Merck Sharp & Dohme Corporation
$56
Alexion Pharmaceuticals, Inc.
$51
ABBVIE INC.
$47
VistaPharm, Inc.
$46
Insulet Corporation
$39
Merck Sharp & Dohme LLC
$35
Hologic Sales and Service, LLC
$30
Mannkind Corporation
$27
Amarin Pharma Inc.
$25
Clarus Therapeutics Inc.
$23
VIVUS LLC
$22
AstraZeneca Pharmaceuticals LP
$22
MannKind Corporation
$20
Verity Pharmaceuticals Inc.
$20
Ultragenyx Pharmaceutical Inc.
$19
iRhythm Technologies, Inc.
$19
IBSA Pharma Inc.
$18
Novartis Pharmaceuticals Corporation
$17
RECORDATI_RARE_DISEASES_INC.
$16
EUSA Pharma (US) LLC
$16
Almatica Pharma LLC
$15
Top 3 companies account for 38.6% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · Crysvita · Dexcom G6 Transmitter · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GVOKE PFS · INPEN SMART INSULIN DELIVERY SYSTEM · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · MINIMED 770G · MOUNJARO · Omnipod · Ozempic · QSYMIA · RECORLEV · RYBELSUS · Rybelsus · SOLIQUA 100/33 · STRENSIQ · SYNTHROID · Strensiq · Sylvant · TEPEZZA · TERIPARATIDE · TOUJEO · TRIDENT SPECIMEN RADIOGRAPHY SYSTEM · TRULICITY · TZIELD · Thyquidity · Tirosint · Tlando · Tymlos · Vascepa · Wegovy · XYOSTED · ZEGALOGUE · ZIO XT Patch · iLet Bionic Pancreas
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Los Gatos?
Compare endocrinologists in the Los Gatos area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
84
Per 100K population
4.4
County median income
$159,674
Nearest hospital
HAZEL HAWKINS MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Maharaj is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Maharaj experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Maharaj performed 314 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maharaj receive payments from pharmaceutical companies?
Yes. Dr. Maharaj received a total of $3,630 from 38 companies across 195 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maharaj's costs compare to other endocrinologists in Los Gatos?
Dr. Maharaj's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maharaj) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →